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Most large DNA viruses, like herpesviruses, encode anti-apoptotic proteins to interfere with the apoptotic cellular response to infection.
Previous studies have shown that the US3 protein kinase of herpes simplex virus, in contrast to US3 of bovine herpes virus 1, is very potent
in protecting cells from apoptosis induced by the virus itself or by a broad range of exogenous apoptotic stimuli. Here, we demonstrate that
US3 of the swine alphaherpesvirus pseudorabies virus (PRV) suppresses PRV-induced apoptosis in swine-testicle (ST) cells at late stages in
infection, and that it protects ST cells from apoptosis induced by either sorbitol or staurosporine. Interestingly, PRV US3 encodes a short and
a long isoform, the latter of which contains a functional mitochondrial localization sequence. Transient transfections showed that the PRV
US3 long isoform is more efficient in protecting ST cells from PRV- or staurosporine-induced apoptosis, suggesting a potential advantage for
the mitochondrial localization of PRV US3 in implementing its anti-apoptotic function.
D 2004 Elsevier Inc. All rights reserved.
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During infection of a cell, most viruses generate pro-
apoptotic signals that enable the host to limit virus replication
and spread. Many viruses, especially large DNAviruses with
a complicated and time-consuming replication cycle, have
evolved various strategies to escape clearance by apoptosis of
the infected cell. Indeed, poxviruses, adenoviruses and
herpesviruses encode multiple anti-apoptotic genes to sup-
press apoptosis (reviewed by Koyama et al., 2000). Over the
last few years, several anti-apoptotic genes have been
identified in both herpes simplex virus serotypes (HSV-10042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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among all a-herpesviruses including the swine pseudorabies
virus (PRV) and the bovine herpesvirus type 1 (BHV-1),
appears to be one of the most potent anti-apoptotic HSV-
encoded proteins. HSV US3 has been reported to counteract
apoptosis triggered by virus infection, the overexpression of a
variety of Bcl-2 family members, CD8+ T cells or various
exogenous inducers such as osmotic shock, UV irradiation
and Fas ligand (Asano et al., 2000; Cartier et al., 2003a,b;
Hata et al., 1999; Jerome et al., 1999; Leopardi et al., 1997;
Murata et al., 2002; Ogg et al., 2004). In spite of the US3
conservation on a genetic level between all a-herpesviruses,
no anti-apoptotic activity could be attributed to the US3
protein of BHV-1 (Takashima et al., 1999).
Interestingly, and unlike HSV and BHV-1, PRV encodes
for two US3 isoforms, an abundant short isoform (N95% of
the US3 protein in infected cells) of 41 kDa and a long05) 144–150
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Zijl et al., 1990). We recently found that both PRV US3
isoforms only differ by the presence of an operational 51
amino acid N-terminally located mitochondrial localization
sequence in the US3 long isoform, which is absent in the US3
short isoform (Van Minnebruggen et al., 2003). Regarding
the pivotal role of mitochondria in apoptosis (Desagher and
Martinou, 2000), this mitochondrial localization of the long
PRV US3 isoform may not be coincidental.
Although it has recently been shown that overexpression
of the short PRV US3 isoform suppresses apoptosis induced
by overexpression of the Bcl-2 family member Bax (Ogg et
al., 2004), nothing is known about the anti-apoptotic
properties of the long isoform of PRV-US3. Further, it is
not known whether PRV US3 has a role in protecting cells
from apoptosis during infection or exogenous apoptotic
stimuli. The aims of the current study were therefore (i) to
investigate whether PRV US3 protects cells from apoptosis
during infection or induced by exogenous inducers like
sorbitol and staurosporine, and, if so, (ii) whether there is a
difference between the long and the short US3 isoform with
this respect.Results
PRV US3 expression suppresses virus-induced apoptosis
The induction of apoptosis is nowadays recognized as a
general cellular response to virus infection, limiting virus
replication and spread (Koyama et al., 2000). In this context,
it has been shown that different members of the a-
herpesvirus family including HSV-1, HSV-2, BHV-1, and
PRV (Aleman et al., 2001; Koyama et al., 1998; Leopardi et
al., 1997; Takashima et al., 1999) trigger apoptosis during
infection. For both HSV serotypes, it was demonstrated that
the US3 protein kinase is able to suppress this virus-inducedFig. 1. PRV US3 protects ST cells from PRV-induced apoptosis at late stages in infe
WT (light gray column), NiA3 US3 null (dark gray columns), or NiA3 US3 Rescu
apoptotic cells was determined either by visualizing active caspase-3 (A) or by T
deviation of triplicate assays.apoptosis (Hata et al., 1999; Leopardi et al., 1997), whereas
no such anti-apoptotic activity could be attributed to BHV-1
US3 (Takashima et al., 1999).
To determine whether the US3 orthologue of PRV
protects cells from apoptosis during PRV infection, swine
testicle (ST) cells were either mock-infected or infected with
wild-type PRV (NiA3 WT), an isogenic US3 deletion
mutant (NiA3 US3 null) or an isogenic US3 rescue strain
(NiA3 US3 R) at an moi of 10. At 6, 12, 18, and 24 h
postinoculation (hpi), cells were collected and processed for
the detection of apoptotic-specific fragmented DNA using
the TUNEL reaction or for the detection of active caspase-3,
the latter of which has been suggested to be one of the most
reliable markers for apoptosis (van Cruchten and van Den
Broeck, 2002).
Fig. 1A shows a slight increase in caspase-3 activation in
ST cells infected with NiA3 WT at 18 and 24 hpi compared
to mock-infected ST cells (4.2 F 1.6% and 4.5 F 0.2% to
1.4 F 0.2%, respectively), indicating that ST cells infected
with wild-type PRV undergo apoptotic cell death to a
limited extent at late stages in infection (z18 hpi). Infection
of ST cells with NiA3 US3 null, however, resulted in a
slight increase in the percentage of active caspase-3-positive
cells at 18 hpi and in a strong increase in active caspase-3-
positive cells at 24 hpi compared to wild-type PRV-infected
cells. At 24 hpi, 42.1 F 2.0% of the NiA3 US3 null-infected
ST cells were positive for active caspase-3 compared to
4.5 F 0.2% and 4.6 F 0.5% active caspase-3-positive cells
after infection with NiA3 wild type or US3 rescue strain,
respectively. Similar results were obtained using the
TUNEL assay (Fig. 1B). Deletion of US3 from the wild-
type NiA3 strain resulted in a slight increase in the number
of TUNEL-positive cells at 12 and 18 hpi compared to the
percentage of TUNEL-positive cells after infection with the
wild type or rescue strain. However, this increase became
very prominent at 24 hpi where deletion of US3 resulted in
39.1 F 3.1% TUNEL-positive cells compared to 5.7 Fction. ST cells were mock-infected (white column) or inoculated with NiA3
e (black column) at an moi of 10. At 6, 12, 18, and 24 hpi, the percentage of
UNEL assay (B). Columns represent the mean, and error bars the standard
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with the wild type or rescue strain, respectively.
Together, these results indicate that the PRV US3 protein
kinase is of critical importance to protect cells from
apoptotic cell death at late stages in infection.
PRV US3 protein kinase blocks apoptosis induced by
sorbitol and staurosporine
HSV-1 and HSV-2 are known to inhibit apoptosis
induced by exogenous stimuli like sorbitol or stauroporine
and US3 is an important anti-apoptotic protein in these
processes (Aubert et al., 1999; Cartier et al., 2003b; Hata et
al., 1999; Murata et al., 2002). In contrast, BHV-1 US3 has
been shown not to be able to inhibit sorbitol-induced
apoptosis (Takashima et al., 1999). Here, we investigated
whether PRV infection protects cells from apoptosis induced
by sorbitol or stauroporine, and, if so, whether this requires
the presence of US3. It has been demonstrated that
incubation of cells with high concentrations of sorbitol
induces apoptosis by altering the structure of the plasma
membrane thereby clustering cell surface receptors and
activating their signal transduction cascade (Rosette and
Karin, 1996), while staurosporine, a protein kinase C
inhibitor, is known to induce apoptosis in a caspase-3-
dependent manner through a mitochondrial-related mecha-
nism (Jacobsen et al., 1996; Khan et al., 2000).
In brief, ST cells were either mock infected or infected
with NiA3 WT, NiA3 US3 null, or NiA3 US3 R at an moi
of 10. At 5 hpi, when there is an abundant expression of
US3 (Van Minnebruggen et al., 2003), apoptosis was
induced with sorbitol or staurosporine as described in
Materials and methods or cells were left untreated.
Caspase-3 activation was monitored at 3 h post treatmentFig. 2. Infection of cells with WT PRV, but not with US3 null PRV, protects ce
infected or inoculated with NiA3 WT, NiA3 US3 null, or NiA3 R at an moi of 10.
(gray columns) with either 3 M sorbitol for 3 h (A) or 1.5 AM staurosporine for 12
active caspase-3 visualization. Relative percentages are given based on the num
staurosporine (B) (each set to 100%). Columns represent the mean, and error bar(sorbitol), corresponding to 8 hpi and at 12 h post treatment
(staurosporine), corresponding to 17 hpi. Since no apparent
differences could be observed in the number of apoptotic
cells detected with the TUNEL assay or active caspase-3
staining in the former experiment and since activated
caspase-3 is the more reliable method of the two (van
Cruchten and van Den Broeck, 2002), the number of
apoptotic cells in the experiments presented here were
determined by staining of activated caspase-3.
Fig. 2 shows relative percentages of apoptosis, com-
pared to mock-infected cells treated with sorbitol (set to
100% in Fig. 2A) or staurosporine (set to 100% in Fig.
2B). Mock-infected cells that were not treated with sorbitol
or staurosporine showed much less apoptosis (relative
percentages of 20.6 F 1.6% and 14.7 F 6.6%, respec-
tively). Caspase-3 activation in sorbitol- or staurosporine-
treated ST cells that were infected with NiA3 WT was
similar as in nontreated mock-infected cells (relative
percentages of 29.8 F 4.0% and 19.8 F 6.0%, respec-
tively), which indicates that PRV infection protects cells
from sorbitol- and staurosporine-induced apoptosis. Cells
inoculated with the NiA3 US3 null virus were not able to
withstand induction of apoptosis by either sorbitol or
staurosporine and the relative percentages of active
caspase-3-positive cells (109.8 F 4.9% and 115.8 F
16.9%, respectively) was comparable as in sorbitol- or
staurosporine-treated mock-infected cells. NiA3 US3 R-
infected ST cells showed a resistance to sorbitol- and
staurosporine-induced apoptosis that was comparable to the
resistance observed in NiA3 WT-infected cells.
Overall, these results show that PRV infection of cells
renders these cells resistant to apoptosis induced by either
sorbitol or staurosporine and that expression of PRV US3 is
absolutely required for this resistance.lls from sorbitol- or staurosporine-induced apoptosis. ST cells were mock-
At 5 hpi, cells were left untreated (white columns) or apoptosis was induced
h (B). After treatment, the percentage of apoptotic cells was determined by
ber of apoptotic cells in mock-infected cells treated with sorbitol (A) or
s the standard deviation of triplicate assays.
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role for the long isoform
The objective of the US3 transient transfection assays
performed in this part of the study was twofold. First, it was
investigated whether PRV US3 can restore the anti-
apoptotic activity in trans in NiA3 US3 null-infected cells
and whether PRV US3 on its own, in the absence of other
viral proteins, can protect cells from staurosporine-induced
apoptosis. Secondly, given that PRV encodes for two US3
isoforms, an abundant short isoform of 41 kDa and a long
isoform of 53 kDa containing a mitochondrial localization
sequence (Van Minnebruggen et al., 2003), we wanted to
investigate whether these two isoforms show a difference in
protecting cells from apoptosis induced by NiA3 US3 null
infection or staurosporine.
Therefore, STcells were transiently transfected with either
the control plasmid encoding LacZ (pLacZ), pKG1, encoding
the PRV NiA3 US3 long isoform, or pKG2, encoding the
PRV NiA3 US3 short isoform. At 24 h post transfection,
apoptosis was induced either by infection with NiA3 US3
null for 24 h (Fig. 3A) or by addition of 1.5 AM staurosporine
for 12 h (Fig. 3B). For both experiments, transfected cells
were visualized using anti-V5 (pLacZ) or anti-US3 (pKG1
and pKG2) antibodies, whereas apoptotic cells were identi-
fied with anti-active caspase-3 antibodies or a TUNEL assay.
The white columns in Fig. 3A show the percentages of
active caspase-3-positive cells, relative to the percentage
obtained in pLacZ-transfected cells that were infected with
NiA3 US3 null (relative value set to 100%). Infection with
NiA3 WT instead of NiA3 US3 null led to a decrease in the
relative percentage of active caspase-3-positive transfected
cells to approximately 60% (P b 0.01, Student’s t test),
indicating once more that the presence of PRV US3 has a
protective effect towards PRV-induced apoptosis. The trans-Fig. 3. Transfection of the long, and, to a lesser extent, the short US3 isoform rest
protects transfected cells from staurosporine-induced apoptosis. ST cells were transi
(PRV US3 long isoform) or pKG2 (PRV US3 short isoform). At 24 h post transfec
for 24 h (A) or cells were left untreated (NT) or treated with 1.5 AM staurosporine f
with anti-V5 antibodies (pLacZ) or anti-US3 antibodies (pKG1 and pKG2) and
columns) or TUNEL assay (gray columns). Relative percentages are given based on
US3 null (A) or treated with staurosporine (B) (each set to 100%). Columns reprfection assay on itself had a pro-apoptotic effect since higher
relative percentages of active caspase-3-positive cells were
observed in pLacZ-transfected NiA3 WT-infected cells
(60.4 F 3.8%, see Fig. 3A) compared to nontransfected,
NiA3 WT-infected cells (25.1%, data not shown). Cells that
were transfected with the US3 short isoform (pKG2) and
subsequently infected with NiA3 US3 null showed a
significant reduction in relative percentage of active cas-
pase-3-positve cells to 77.5% compared to cells transfected
with pLacZ (100%) (P b 0.05, Student’s t test). Cells that
were transfected with the long isoform (pKG1) showed a
much stronger protection against apoptosis induced by
NiA3 US3 null (relative percentage of apoptosis of 49.7%)
(P b 0.01, Student’s t test). An analogous experiment was
performed, but now using the TUNEL assay for analyzing the
relative percentage of apoptotic cells (gray columns in Fig.
3A). This experiment gave similar results compared to the
analysis of apoptosis with anti-active caspase-3 antibodies.
Transfection with pKG1, but not pKG2, and subsequent
infection with US3 null virus resulted in co-localization
between US3 and mitochondria, indicating that the trans-
fected long US3 isoform not only targets to mitochondria in
noninfected cells (VanMinnebruggen et al., 2003), but also in
an infection background (data not shown).
Similar results were obtained using staurosporine to
induce apoptosis and are shown in Fig. 3B. Percentages
given are again relative values: the number of apoptotic cells
as detected by anti-active caspase-3 antibodies (white
columns) or by the TUNEL assay (gray columns) in
staurosporine-treated cells that were transfected with a
control plasmid (pLacZ) was set to 100%. Again, cells
transfected with the US3 short isoform (pKG2) prior to
treatment with staurosporine were able to reduce caspase-3
activation to some extent compared to cells transfected with
the control plasmid LacZ (80.6 F 4.5% and 100%,ores anti-apoptotic activity in trans in NiA3 US3 null-infected ST cells, and
ently transfected either with a control plasmid, pLacZ, or the plasmids pKG1
tion, cells were inoculated with NiA3 WT or NiA3 US3 null at an moi of 10
or 12 h to induce apoptosis (B). Afterwards, transfected cells were visualized
apoptotic cells were visualized by anti-active caspase-3 antibodies (white
the number of apoptotic cells in pLacZ-transfected cells infected with NiA3
esent the mean, and error bars the standard deviation of triplicate assays.
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cells transfected with the US3 long isoform (pKG1) were
able to reduce levels of staurosporine-induced caspase-3
activation to (below) the level of nontreated pLacZ-
transfected cells (50.0 F 0.4% and 57.5 F 4.5%,
respectively; P b 0.01, Student’s t test). Again, analogous
results were acquired using the TUNEL assay (gray
columns in Fig. 3B). The expression level of US3 was
similar in cells transfected with either the US3 long or the
US3 short isoform, indicating that the stronger anti-
apoptotic effect of US3 in cells transfected with the long
US3 isoform versus cells transfected with the US3 short
isoform was not due to differences in expression level (data
not shown).
Together, these results clearly indicate that transient
transfection of PRV US3 can restore the anti-apoptotic
activity in trans in NiA3 US3 null-infected cells and that
US3 on its own, in the absence of other viral proteins,
possesses anti-apoptotic activity since transfection protects
cells from staurosporine-induced apoptosis. Additionally,
the PRV US3 long isoform displays more robust potency in
protecting cells from apoptosis induced by PRV or
staurosporine compared to its short isoform, thereby
suggesting the potential importance of the mitochondrial
localization of PRV US3 in implementing its anti-apoptotic
function.Discussion
Expression of anti-apoptotic proteins by large DNA
viruses like herpesviruses is a prerequisite to counteract the
pro-apoptotic triggers during infection that enable the host
to limit virus replication and spread. In the current study, it
was our goal to investigate the potential anti-apoptotic
function of the US3 protein kinase of the porcine a-
herpesvirus pseudorabies virus (PRV). We demonstrated
that infection of swine testicle (ST) cells with wild-type
PRV leads to a limited extent of apoptotic cell death at late
stages in infection, but that infection with a US3 null virus
results in extreme apoptotic cell death at 24 hpi (Figs.
1A,B). The observation that a US3 null virus only causes
extensive apoptotic cell death at late stages in infection, may
suggest that, besides US3, other viral proteins may be
involved in anti-apoptotic activities earlier in infection.
Indeed, for HSV, in addition to US3, several other viral-
encoded proteins have been suggested to display anti-
apoptotic characteristics that may act at early stages in
infection, such as HSV-1 ICP4, ICP27, ICP22, US5, US6
(reviewed by Aubert and Blaho, 2001), ICP34.5 (Chou and
Roizman, 1992), and HSV-2 ICP10 (Perkins et al., 2002).
Further, we also demonstrated that PRV US3 is able to
suppress apoptosis induced by exogenous stimuli like
sorbitol and staurosporine. Interestingly, although the US3
gene is conserved among all members of the a-herpesvi-
ruses, its anti-apoptotic function does not seem to be equallywell conserved. It has been demonstrated that herpes
simplex virus (HSV) US3 is necessary for the inhibition
of apoptosis in infected cells and in cells subjected to
different apoptotic stimuli (Asano et al., 2000; Cartier et al.,
2003a,b; Hata et al., 1999; Jerome et al., 1999; Leopardi et
al., 1997; Murata et al., 2002; Ogg et al., 2004). On the
other hand, Takashima et al. (1999) demonstrated that the
bovine herpesvirus type 1 (BHV-1) US3 protein kinase does
not seem to possess anti-apoptotic properties and, conse-
quently, is not involved in protecting cells from apoptotic
cell death during BHV-1 infection.
The PRV US3 gene, unlike its HSV and BHV-1
orthologues, encodes two isoforms: a short US3 isoforms
that localizes to the nucleus and diffusely to the cytoplasm,
and a long US3 isoform that contains a mitochondrial
localization sequence (MLS) that targets its predominantly
to mitochondria (Calton et al., 2004, Van Minnebruggen et
al., 2003). A recent report by Ogg et al. (2004) showed that
the short isoform of PRV US3 possesses anti-apoptotic
properties in Bax-overexpressing cells. However, these
authors did not explore the potential anti-apoptotic proper-
ties of the long US3 isoform. By performing transfection
experiments using US3 expression vectors that encode
either the long or short isoform, we showed that expression
in trans of the PRV US3 short isoform can only partially
restore the anti-apoptotic activity of US3 during virus
infection and that this recombinant US3 short isoform can
only partially protect cells from staurosporine-induced
apoptosis. However, expression of the PRV US3 long
isoform in trans completely restored the anti-apoptotic
activity of US3 during virus infection and transfection of the
long isoform protected cells much more potently against
staurosporine-induced apoptosis than the short US3 isoform.
Based on these results, it is tempting to speculate that the
predominant mitochondrial localization of the long US3
isoform may be beneficial for the anti-apoptotic activity of
PRV US3. Although the mechanism how PRV US3 exerts
its anti-apoptotic function is not yet known, and although
HSV US3 has to data not been reported to contain a MLS, it
is possible that PRVexerts its anti-apoptotic activity through
similar mechanisms as HSV US3. Different hypotheses
could then be given how the mitochondrial localization of
PRV US3 may be advantageous, albeit not absolutely
required, for its anti-apoptotic effect. Pro-apoptotic proteins
that have thus far been shown to be targets for HSV US3-
mediated interference such as Bid and Bad are known to
travel from the cytoplasm to mitochondria to exert their pro-
apoptotic effect (reviewed by Burlacu, 2003). Hence,
although the PRV US3 short isoform and HSV US3, which
both have been shown to be present in the cytoplasm, may
be able to interfere with the pro-apoptotic activity of these
proteins (Benetti et al., 2003; Cartier et al., 2003a,b; Munger
and Roizman, 2001; Ogg et al., 2004), the chance of
encountering these pro-apoptotic targets by US3 may
increase significantly when it localizes to mitochondria.
Alternatively, mitochondria-localized US3 may have access
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counteract apoptosis, thereby resulting in a more potent anti-
apoptotic effect. It will, therefore, be interesting to unravel
the exact mechanism of the anti-apoptotic activity of PRV
US3 and to find an answer on whether and how the
difference in localization between the long and short US3
isoform results is the difference in efficiency of counter-
acting apoptosis that we observed here.Materials and methods
Cells, virus strains, and inoculation
Cells
Swine testicle (ST) cells were cultured in ST culture
medium [Eagle’s minimal essential medium (MEM) sup-
plemented with 10% fetal bovine serum (FBS), 100 U/ml
penicillin, 0.1 mg/ml streptomycin, 0.1 mg/ml kanamycin,
and 0.3 mg/ml glutamin].
Virus strains
Virulent pseudorabies virus wild-type strain NiA3 (NiA3
WT), NiA3 US3 deletion mutant (NiA3 US3 null), and
NiA3 US3 rescue strain (NiA3 US3 R) were used and were
described earlier (Baskerville et al., 1973; Kimman et al.,
1992; van Zijl et al., 1990). The PRV US3 null virus was
constructed by insertion of a 20-mer oligonucleotide,
containing TAG translational stop codons in all reading
frames, in the 5Vpart of the US3 open reading frame.
Inoculation
ST cells were inoculated with either of the NiA3 strains
at a multiplicity of infection of 10 TCID50 in culture
medium. After incubation for 1 h at 37 8C, the inoculum
was aspirated and fresh culture medium was added.
Antibodies and reagents
US3-specific mouse monoclonal antibodies were gener-
ated at the Princeton University monoclonal antibody facility
against a fusion protein consisting of the c-terminal 476
amino acids of US3 and GST, and purified using GST-
agarose. Mouse monoclonal antibodies directed against V5
were purchased from Invitrogen (Groningen, The Nether-
lands). Rabbit polyclonal antibodies directed against active
caspase-3 were obtained from R&D Systems Inc. (Minne-
apolis, MN, USA) and the secondary antibodies Texas Red-
conjugated goat anti-mouse IgG and FITC-conjugated goat
anti-rabbit IgG were obtained from Molecular Probes
(Eugene, OR, USA). DNA fragmentation was detected based
on the TUNEL reaction using the In Situ Cell Death
Detection Kit (Fluorescein) obtained from Roche (Man-
nheim, Germany). The apoptotic inducers D-sorbitol and
staurosporine were purchased from Sigma Chemical Com-
pany (St. Louis, MO, USA).Induction of apoptosis
Induction of apoptosis by osmotic shock was based on a
previous report (Koyama and Miwa, 1997). Cells were
incubated with 3M D-Sorbitol in ST culture medium without
FBS for 1 h. Cells were then washed twice in sorbitol-free
medium and incubated further in ST culture medium for 2 h.
For the induction of apoptosis with staurosporine, cells were
washed twice in ST culture medium with 1% FBS and
subsequently incubated with 1.5 AM staurosporine in ST
culture medium with 1% FBS for 12 h.
Construction of expression vectors and transfection assay
The sequence encoding the US3 long isoform was PCR-
amplified from the DNA of PRV NiA3 WT strain with
Platinum pfx DNA polymerase (Invitrogen) by use of the
forward primer 5VCACCTGTGGGCCAGCGCGTAGTA3V
and the reverse primer 5VCACTTCATTGTTGAGCTGTQ
GGAGAT3V, in the presence of 4% dimethylsulfoxide
(DMSO). The PCR reaction consisted of an initial 2 min,
30 s denaturation step at 94 8C, followed by 35 cycles of
denaturation (94 8C, 45 s), annealing (59 8C, 45 s), and
extension (68 8C, 1 min, 30 s), and a final 10-min extension
step. The PCR-amplified US3 long isoform encoding
sequence was cloned into the pcDNA3.1D/V5-HIS-TOPO
vector following the manufacturer’s instructions (Invitro-
gen) to create pKG1, encoding the long US3 isoform.
Plasmid pKG2, encoding the short US3 isoform, was
generated as follows: pKG1 was digested with HindIII
and Eco47III, releasing a 229-bp fragment, blunt ended
using T4 DNA polymerase (Invitrogen) and religated.
Next, plasmids pKG1, pKG2, or control plasmid
pcDNA3.1D/V5-His/lacZ (pLacZ) (Invitrogen) were tran-
siently transfected in ST cells grown to 90% confluence
using Lipofectamine and Plus Reagent according to the
manufacturer’s instructions (Invitrogen). At 24 h post
transfection, cells were either infected with NiA3 WT or
NiA3 US3 null strain for 24 h or treated with 1.5 AM
staurosporine for 12 h. Cells were collected and further
processed for immunofluorescence staining.
Immunofluorescence staining procedures
All staining procedures were performed in suspension to
prevent loss of apoptotic cells. Cells were detached using
PBS without Ca2+ and Mg2+ containing 0.5 mM EDTA.
After being washed in ice-cold PBS, cells were fixed with
3% paraformaldehyde for 10 min on ice followed by
permeabilization with 0.2% Triton X-100 in RPMI-1640
(Gibco BRL, Life Technologies Inc., Gaitersburg, MD) for
3 min on ice. Antibodies, at all times incubated for 1 h at
37 8C, were always diluted in PBS: anti-US3 (1:80), anti-
active caspase-3 (1:100), or anti-V5 (1:300) for primary
antibody dilutions, and Texas Red-conjugated goat anti-
mouse IgG (1:50) and FITC-conjugated goat anti-rabbit IgG
K. Geenen et al. / Virology 331 (2005) 144–150150(1:100) for secondary antibody dilutions. The detection of
fragmented DNA with the TUNEL reaction was performed
according to the manufacturer’s instruction (Roche). All
cells were counterstained using Hoechst (Molecular Probes)
and mounted in a glycerin-PBS solution (0.9:0.1, vol/vol)
with 2.5% 1,4-diazabicyclo(2.2.2)octane (Janssen Chemica,
Beerse, Belgium) and analyzed by fluorescence microscopy.
For each experiment, 200 cells were scored. Each
experiment was repeated three times and results are
presented as mean (relative) percentages with corresponding
standard deviations.Acknowledgments
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